Radiodermatitis Market to Hit $609.68 Mn, Globally, by 2027 at 4.1% CAGR, Says Allied Market Research

Rise in the geriatric population, surge in prevalence of cancer, and increase in adoption of radiotherapy have boosted the growth of the global radiodermatitis market

PORTLAND, Ore., Oct. 5, 2020 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Radiodermatitis Market by Product (Topical, Oral Drugs, and Dressings) and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2019–2027". As per the report, the global radiodermatitis industry was pegged at $477.48 million in 2019, and is anticipated to reach $609.68 million by 2027, growing at a CAGR of 4.1% from 2020 to 2027.

Request for Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/4498?reqfor=covid

Drivers, restraints, and opportunities

Rise in the geriatric population, surge in prevalence of cancer, and increase in adoption of radiotherapy have boosted the growth of the global radiodermatitis market. However, higher radiodermatitis cost hampers the market growth. On the contrary, reduction of side effects associated with radiation therapy is expected to create lucrative opportunities for the market players in the coming years.

Covid-19 scenario:

• After the Covid-19 outbreak, the patients with cancers are regarded as a high-risk group as they require hospital visits for radiation therapy.
• However, the demand for radiodermatitis is expected to decline during the pandemic, due to various manufacturers in radiodermatitis have been facing issues in the supply of their products.

The topical segment dominated the market

By product, the topical segment held the lion's share in 2019, accounting for more than four-fifths of the global radiodermatitis market, owing to easier application, cost-effectiveness, and its bioavailability. However, the dressing segment is expected to register the highest CAGR of 5.0% during the forecast period, due to presence of a wide range of dressing products in the market and rise in demand for advanced wound care options.

The online pharmacy segment to portray the highest CAGR through 2027

By distribution channel, the online pharmacy segment is expected to manifest the highest CAGR of 5.0% during the forecast period, due to inconvenience for patients, in terms of home delivery of products to purchase medicines from retail or hospital pharmacy. However, the retail pharmacy segment held the largest share in 2019, contributing to more than three-fifths of the global radiodermatitis market, owing to availability of affordable product options, near store locality, and availability of the generic form of drugs.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4498

North America to manifest the highest CAGR during 2020–2027

By region, the market across North America is expected to register the highest CAGR of 5.1% during the forecast period, owing to the inclusion of radiodermatitis products in reimbursement healthcare policy, rise in number of cancer patients, surge in demand for radiation therapy, and high expenditure in the healthcare sector. However, the global radiodermatitis market across Asia-Pacific held the largest share in 2019, accounting for more than two-fifths of the market, due to rise in disposable income, increase in expenditure on healthcare, rise in prevalence of cancer patients, and growth in adoption of advanced healthcare products.

Major market players

• Bausch Health Companies Inc
• 3M Company
• BMG Pharma SPA
• Bayer Ag
• Glaxosmithkline Plc
• Convatec Group Plc
• Molnlycke Health Care
• Helsinn Healthcare SA
• Smith & Nephew Plc
• Mylan N.V.
• Stratpharma Ag.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

U.S. Patient Monitoring Systems Market - Opportunity Analysis & Industry Forecast, 2020–2026

Organ-on-Chip Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

U.S. Advanced Wound Care Market - Opportunity Analysis and Industry Forecast, 2019-2026

VR in Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2019–2026

Europe Digital Therapeutics Market - Opportunity Analysis and Industry Forecast, 2019–2026

Disposable Syringes Market Global Opportunity Analysis and Industry Forecast, 2019–2026

Pharmaceutical Drug Delivery Market Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research